Loading...
•
Sep 30, 2022
Biolase Q3 2022 Earnings Report
Reported 26% revenue growth year over year.
Key Takeaways
BIOLASE, Inc. announced its financial results for the third quarter ended September 30, 2022, with total revenue of $12.0 million, up 26% year over year. U.S. laser sales increased 35% year over year and U.S. consumable sales increased 22% year over year. The company is increasing its 2022 full year revenue guidance and now expects full year net revenue to increase at least 20% from 2021 levels.
Total revenue was $12.0 million, up 26% year over year
U.S. laser sales increased 35% year over year and U.S. consumable sales increased 22% year over year, driven by increased procedures using BIOLASE lasers
Over 90% of U.S. Waterlase sales coming from new customers and approximately 40% of U.S. Waterlase sales coming from dental specialists
Waterlase Exclusive Trial Program success rate remained at over 50% year to date, highlighting the program’s success
Biolase
Biolase
Biolase Revenue by Segment
Revenue by Segment
US Laser Revenue
CapyFin.com Forward Guidance
BIOLASE is anticipating fourth quarter net revenue to exceed $13.0 million, which would represent growth of at least 5% year over year. The Company is increasing its 2022 full year revenue guidance and now expects full year net revenue to increase at least 20% from 2021 levels.